JUMP REPORT
| Avg Daily Volume: 1,175,032 Market Cap: 3.66B Sector: Technology Short Interest: 8.58 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: .35/share REV: 85.3/M
___________________________________________________________
LAST QTR: EPS: .33/share ACTUAL: .41/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .31/share REV: 83.9/M
______________________________________________________
FULL YR: EPS: 1.33/share REV: 343.3/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 91% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) 4.89, -4.06, -13.75
POTENTIAL JUMP MOVE: 8-10%
Links To Latest News and Headlines
Investment company Radnor Capital Management, LLC (Current Portfolio) buys Microsoft Corp, Apple Inc, International Business Machines Corp, Procter & Gamble Co, Johnson & Johnson, sells Xylem Inc, AT&T Inc, HealthEquity Inc, PayPal Holdings Inc, FIGS Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Radnor Capital Management, LLC.
Shares of health savings account (HSA) specialist HealthEquity (NASDAQ: HQY) were zooming well into the black this week. HealthEquity issued a business update that morning in advance of a company presentation at a healthcare industry conference. HealthEquity’s estimate for that line item is approximately $19.8 billion, representing growth of roughly 38%.
» HealthEquity Announces Record HSA Sales Outlook, Presentation at J.P. Morgan Healthcare Conference
DRAPER, Utah., Jan. 10, 2022 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the nation’s largest independent health savings account (“HSA”) custodian, today announced estimates of HSAs, HSA assets and total accounts for its fiscal year ending on January 31, 2022, reflecting record new openings and custodial asset growth. Estimated HSAs are expected to be approximately 7.2 million by January 31, 2022, up from 5.8 million a year earlier.Estimated HSA assets
HealthEquity (HQY) reported earnings 30 days ago. What’s next for the stock? We take a look at earnings estimates for some clues.
» Five stocks to buy because company insiders love them as they get hit by year-end tax-loss selling
Every year around this time, two powerful forces conspire to artificially suppress stock prices — and create bargains: Lust and vanity. As for the first force — the lust for profits — this is when individual investors dump losers to create tax losses to offset gains. The second force — vanity — has fund managers putting “window dressing” on their portfolios to get out of losers so they don’t have to show them in annual reports, points out Bruce Kaser, editor of the Cabot Turnaround Letter.
StockJumpers analysis and trade plans are uploaded generally 1 HOUR (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.